In summary, most of the putative off-targets for CETP inhibitors are involved in interconnected lipid metabolism and signaling networks which activate or mediate various biological process such as hypertension, stress regulation [78], immune response [79] and cell death [80]. This evidence concerns the gene CETP and hypertensive disorder.